{"name":"MediWound Ltd","slug":"mediwound-ltd","ticker":"","exchange":"","domain":"mediwound.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2022-01-01","label":"Nexobrid first approved","drug":"Nexobrid","drugSlug":"anacaulase","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-01","label":"NEXOBRID Phase 3 readout (Venous Leg Ulcer (VLU))","drug":"NEXOBRID","drugSlug":"anacaulase-bcdb","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"DGD","genericName":"DGD","slug":"dgd","indication":"Enzymatic debridement of eschar in thermal burns","status":"phase_3"},{"name":"EscharEx (EX-03)","genericName":"EscharEx (EX-03)","slug":"escharex-ex-03","indication":"Thermal burns requiring eschar removal","status":"phase_3"},{"name":"NEXOBRID","genericName":"ANACAULASE-BCDB","slug":"anacaulase-bcdb","indication":"Removal of escars from deep thermal burn","status":"marketed"},{"name":"NexoBrid","genericName":"NexoBrid","slug":"nexobrid","indication":"Thermal burns requiring eschar removal","status":"marketed"},{"name":"Nexobrid","genericName":"anacaulase","slug":"anacaulase","indication":"Removal of escars from deep thermal burn","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"EscharEx","genericName":"EscharEx","slug":"escharex","indication":"Treatment of diabetic foot ulcers","status":"phase_2"}]}],"pipeline":[{"name":"DGD","genericName":"DGD","slug":"dgd","phase":"phase_3","mechanism":"DGD is a recombinant protease that selectively debrides necrotic tissue by breaking down denatured collagen and proteins in burn wounds.","indications":["Enzymatic debridement of eschar in thermal burns","Removal of necrotic tissue in deep partial and full-thickness burn wounds"],"catalyst":""},{"name":"EscharEx","genericName":"EscharEx","slug":"escharex","phase":"phase_2","mechanism":"EscharEx is a topical enzyme therapy that degrades necrotic tissue.","indications":["Treatment of diabetic foot ulcers","Treatment of venous leg ulcers"],"catalyst":""},{"name":"EscharEx (EX-03)","genericName":"EscharEx (EX-03)","slug":"escharex-ex-03","phase":"phase_3","mechanism":"EscharEx is a topical enzymatic debriding agent that selectively removes necrotic tissue from burns and wounds.","indications":["Thermal burns requiring eschar removal","Enzymatic debridement of burn wounds"],"catalyst":""},{"name":"NEXOBRID","genericName":"ANACAULASE-BCDB","slug":"anacaulase-bcdb","phase":"marketed","mechanism":"","indications":["Removal of escars from deep thermal burn"],"catalyst":""},{"name":"NexoBrid","genericName":"NexoBrid","slug":"nexobrid","phase":"marketed","mechanism":"NexoBrid is a topical enzymatic debriding agent containing bromelain that selectively removes necrotic tissue from burn wounds.","indications":["Thermal burns requiring eschar removal"],"catalyst":""},{"name":"Nexobrid","genericName":"anacaulase","slug":"anacaulase","phase":"marketed","mechanism":"Nexobrid works by breaking down the eschar, a dead layer of skin, to facilitate its removal.","indications":["Removal of escars from deep thermal burn"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-11-23","type":"earnings","source":"simplywall.st","summary":"The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st","headline":"The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-16","type":"pipeline","source":"simplywall.st","summary":"Getting In Cheap On MediWound Ltd. (NASDAQ:MDWD) Might Be Difficult - simplywall.st","headline":"Getting In Cheap On MediWound Ltd. (NASDAQ:MDWD) Might Be Difficult","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQanZqa1BRTU1VQjc2cDRxbEJILU1RUFR4ZHB2WF9uQWVkM0NRSVFGRFg1Vm80T2k4RFBxTkJwZDV0a3pMaG4wZmE1Tjg3M3dnS2FySVpmbFBtQ1hEQU51dEZYeEVUbkRtNnpvR194Wmc0Wklmczd2Q2NLTTZ6bzhnRzhyVW5vRkxBRkRkZFlSeUJDTE02ejZuOFdaTzhRa2xDalhUdE1qNzdJZk1HWU5GMHpiY2RSSWpyc202dA?oc=5","date":"2023-08-02","type":"pipeline","source":"BioSpectrum Asia","summary":"Israel's MediWound announces launch of biologic drug NexoBrid in Japan - BioSpectrum Asia","headline":"Israel's MediWound announces launch of biologic drug NexoBrid in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTDM1LTVDNzB0YU1xUldodURyUjQ3a0Qxc0pXWTJ1M1RZdFBRSW9SN1AxZlJsWEZoSXFzTGREZ3VvR3ZZTUNBdi1RX3pXZlJLZkNQb3ViaXhCb19xZElhRzJJcjhDbTB0OEZzaWlSMHdFd0dON3NXdHJIT3JTTWFiajNJN2RDQWJVcWI3S25Jb0xBQ2c0eDl4OThMVWRIR1RoNmswNEZXTjREUGJfaGJIV1hpdmFJUVVFZ3ZB?oc=5","date":"2023-05-29","type":"regulatory","source":"Citeline News & Insights","summary":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","headline":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2022-12-14","type":"pipeline","source":"Medical Dialogues","summary":"Bharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in India - Medical Dialogues","headline":"Bharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1ubHVpZWx5VEdJX2kxZWpFUDFpQU5nWjdpanBFRzl5SWZncmFpUWZrSHh3aUE0Vi10UndMX1VjWUVFUXdCRDJjZWFVWlRqSnd6a1VDQzFTTjNtZmRobjJzQ0JjXzE4TWxmTG5z?oc=5","date":"2021-07-19","type":"earnings","source":"Zacks Investment Research","summary":"What date does MediWound's (MDWD) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research","headline":"What date does MediWound's (MDWD) report Earnings - Earnings Calendar & Announcement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOY1hoNEVBS1A0NjV6WkVZMVRQOWVRc0xwWWxaQzMyaXpDMTZ3dlV5bnpJMU8tb1Eza2RibzlqejZBNURnUXBmTUdBNDBhZ3pGSWpvNlhJaWR0ZFcxYkk3TGg5eGJ0YmFXX0RKa2E2eWpoMHY0cEV0a3lHbVNrRUVmS3pENU0?oc=5","date":"2021-07-02","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Teva increases stake in Mediwound to 51% - Generics and Biosimilars Initiative","headline":"Teva increases stake in Mediwound to 51%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUWcwMlVNb2piZlRxNjdULWNicUdHZ211NVVrdXlzVTh6WHpibkhzRGQtWEF2NWp3WGd5RE5qNGlmdDVGLXh5el9HZVVlUmhYbld1NWZsdGYzTmpELTlReWE0blgtVC1vamVfM0xwMFJlR3FkQ280NE81T0tWcWVpeHJWbzlJM0pxbzFRR29hYmYzU0E?oc=5","date":"2018-11-25","type":"pipeline","source":"Globes - Israel Business News","summary":"Teva's loss is Israeli pharma industry's gain - Globes - Israel Business News","headline":"Teva's loss is Israeli pharma industry's gain - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5mdlM0SnNfTDlkZC1IamtmMFRFTTFwSEtTbDJYSTN1QjJjbTFHQ2xNTG9Wc19GTUlaS0ROUWpSZU8zRUR6TUt5OWs1Rk9NT1pJdVFKZ09US2dzM2hadl93eWpUbmp3Y1JXenZBM1o1Z1B3TTk2Q2NF?oc=5","date":"2018-05-31","type":"pipeline","source":"CTech","summary":"MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns - CTech","headline":"MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1jYm5XaXNtbWZDLVo5ZkkwZFdHcEJYU0pPelZBOHdhakVDRWdMX21IR0llMXJrdmZsbG9oQ0ZmM2xfREsyNS15ZUh1SERlSUdhdDd4bG5Rek51RjBBMWFjZ3RLWDV4OHg5bklfVS1mTl9nMmIzN1dJ?oc=5","date":"2017-11-07","type":"pipeline","source":"CTech","summary":"Biotech Company Struggling to Convince Doctors to Treat Burns with Pineapples - CTech","headline":"Biotech Company Struggling to Convince Doctors to Treat Burns with Pineapples","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBzUG95RTROZUN5TkU2SmRaRzgtb1NmSFBHcU9GNU9RM1hmY3E1TFRSZ2RGUEJVOF9ULTdwUldOZGZUYjFxMTI0ekVxOG5EUTBYdFI5dV9ULXpxdnlL?oc=5","date":"2017-07-21","type":"pipeline","source":"TradingView","summary":"MDWD Stock Price and Chart — NASDAQ:MDWD - TradingView","headline":"MDWD Stock Price and Chart — NASDAQ:MDWD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFA0czlJZndPVzRwYUp5SFdpUnpQbEtSSHRiZmRfUE1GM012N09KaFdXSHdnQjlDTUFJWlhIYWNFb3VUSVZNcEV1aEEtZ3pSZDg5OXc?oc=5","date":"2017-05-14","type":"pipeline","source":"Yahoo Finance Singapore","summary":"MediWound Ltd. (MDWD) stock price, news, quote and history - Yahoo Finance Singapore","headline":"MediWound Ltd. (MDWD) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":2,"phase_2":1,"marketed":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}